181 related articles for article (PubMed ID: 19073002)
21. A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens.
Woolgar JA; Triantafyllou A
Oral Oncol; 2005 Nov; 41(10):1034-43. PubMed ID: 16129652
[TBL] [Abstract][Full Text] [Related]
22. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of human papillomavirus and other risk factors in Lithuanian patients with head and neck cancer.
Gudleviciene Z; Smailyte G; Mickonas A; Pikelis A
Oncology; 2009; 76(3):205-8. PubMed ID: 19209011
[TBL] [Abstract][Full Text] [Related]
24. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
25. Perception of head and neck cancer quality of life within the medical world: a multicultural study.
Demez PH; Moreau PR
Head Neck; 2009 Aug; 31(8):1056-67. PubMed ID: 19340871
[TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
[TBL] [Abstract][Full Text] [Related]
27. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
28. Upper gastrointestinal cancer pathology reporting: a regional audit to compare standards with minimum datasets.
King PM; Blazeby JM; Gupta J; Alderson D; Moorghen M
J Clin Pathol; 2004 Jul; 57(7):702-5. PubMed ID: 15220361
[TBL] [Abstract][Full Text] [Related]
29. [New therapeutic options for head and neck squamous cell carcinomas].
Dietz A
HNO; 2008 Jun; 56(6):572. PubMed ID: 18483715
[No Abstract] [Full Text] [Related]
30. Usefulness of a synoptic data tool for reporting of head and neck neoplasms based on the College of American Pathologists cancer checklists.
Kang HP; Devine LJ; Piccoli AL; Seethala RR; Amin W; Parwani AV
Am J Clin Pathol; 2009 Oct; 132(4):521-30. PubMed ID: 19762529
[TBL] [Abstract][Full Text] [Related]
31. Lymphatic vessel density in correlation to lymph node metastasis in head and neck squamous cell carcinoma.
Frech S; Hörmann K; Riedel F; Götte K
Anticancer Res; 2009 May; 29(5):1675-9. PubMed ID: 19443385
[TBL] [Abstract][Full Text] [Related]
32. Rare involvement of submandibular gland by oral squamous cell carcinoma.
Chen TC; Lo WC; Ko JY; Lou PJ; Yang TL; Wang CP
Head Neck; 2009 Jul; 31(7):877-81. PubMed ID: 19360744
[TBL] [Abstract][Full Text] [Related]
33. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
34. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
[TBL] [Abstract][Full Text] [Related]
36. [Malignant multiple neoplasms in head and neck squamous cell carcinoma].
López Mollá C; Estellés Ferriol E; Carrasco Llatas M; Seijas Rosales T; Morales Suárez-Varela M; Dalmau Galofre J
Acta Otorrinolaringol Esp; 2008 Nov; 59(9):427-32. PubMed ID: 19080772
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
Fabricius EM; Kruse-Boitschenko U; Khoury R; Wildner GP; Raguse JD; Klein M
Int J Oncol; 2009 May; 34(5):1257-79. PubMed ID: 19360339
[TBL] [Abstract][Full Text] [Related]
38. Hypercalcemia in advanced head and neck squamous cell carcinoma: prevalence and potential impact on palliative care.
Alsirafy SA; Sroor MY; Al-Shahri MZ
J Support Oncol; 2009; 7(5):154-7. PubMed ID: 19831158
[TBL] [Abstract][Full Text] [Related]
39. Making the most of your pathology: standardized histopathology reporting in head and neck cancer.
Yunker WK; Matthews TW; Dort JC
J Otolaryngol Head Neck Surg; 2008 Feb; 37(1):48-55. PubMed ID: 18479628
[TBL] [Abstract][Full Text] [Related]
40. Personalizing cancer care: updates on head and neck cancer.
de Souza JA; Cohen EE
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1219-22. PubMed ID: 19761425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
